ImmunoPrecise Antibodies Ltd. (HYFT) Live Share Price, Invest From India

ImmunoPrecise Antibodies Ltd. Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$1.26
Day's Price Range
$1.31
$1.27
0.79%
Downside
3.15%
Upside
52 Week's Low
52 Week's High
$0.99
52-Week Price Range
$2.99
$1.27
22.05%
Downside
135.43%
Upside

ImmunoPrecise Antibodies Ltd. share price movements today

Previous Close: $1.32
Open: $1.31
Volume: 864.7K
Day's Low - High: $1.26 - $1.31
52 Week Low - High: $0.99 - $2.99

ImmunoPrecise Antibodies Ltd. Historical Returns

1 Month Return: + 23.36 %
3 Month Return: -3.65 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

ImmunoPrecise Antibodies Ltd. Stock Fundamentals & Key Indicators

Check ImmunoPrecise Antibodies Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$59.3M

EPS (TTM)

-0.224

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-58.82%

ImmunoPrecise Antibodies Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ImmunoPrecise Antibodies Ltd. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
ImmunoPrecise Antibodies Ltd.	NA	$59.3M	NA	NA	-43.60%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in ImmunoPrecise Antibodies Ltd. Stock

Search interest for ImmunoPrecise Antibodies Ltd. Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:29% versus previous 30 day period

ImmunoPrecise Antibodies Ltd. Quarterly Profit & Loss

All numbers in Millions USD

	Oct 2023	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Total Revenue	6	6	4	1	1	4	4	3	4	4
Gross Profit	2	2	1	0	0	1	3	1	2	2
Operating Income	-2	-3	-3	-4	-4	-3	-1	-4	-2	-3
EBITDA	-1	-2	-17	-3	-2	-24	0	-3	-3	-3
Interest Expense	0	0	0	0	0	0	0	-	-	-
Depreciation	-	-	1	1	1	1	0	0	0	0
Income Before Tax	-2	-3	-18	-4	-4	-25	-1	-4	-3	-3
Income Tax Expense	0	0	-1	0	0	-3	0	0	0	0
Net Income	-2	-2	-12	-2	-1	-15	-1	-2	-3	-3
Net Profit Margin	-39.17%	-43.06%	-272.64%	-161.71%	-95.30%	-349.88%	-30.96%	-93.61%	-77.47%	-94.52%

ImmunoPrecise Antibodies Ltd. Annual Profit & Loss

All numbers in Millions USD

	Apr 2016	Apr 2017	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Total Revenue	1	2	5	11	14	17	15	15	18	17
Gross Profit	0	0	-1	-1	0	11	7	5	6	8
Operating Income	0	-1	-4	-6	-4	-3	-17	-29	-14	-12
EBITDA	0	-5	-4	-4	-1	-4	-12	-21	-23	-28
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	3	6	5	5
Income Before Tax	0	-5	-5	-7	-5	-5	-16	-28	-29	-33
Income Tax Expense	0	0	0	0	0	1	0	-1	-2	-3
Net Income	0	-5	-5	-7	-5	-7	-13	-20	-19	-21
Net Profit Margin	-1.82%	-204.67%	-95.03%	-69.72%	-35.19%	-40.98%	-86.29%	-128.53%	-106.51%	-123.30%

ImmunoPrecise Antibodies Ltd. Quarterly Cash Flow

All numbers in Millions USD

	Jan 2024	Apr 2024	Jul 2024	Oct 2024	Jan 2025	Apr 2025	Jul 2025	Oct 2025	Jan 2026
Net Income	-1	-18	-3	-2	-21	-2	-2	-3	-3
Operating Cash Flow	0	-2	-1	-2	-1	-1	-4	-2	-2
Investing Cash Flow	0	-1	0	0	0	0	0	0	13
Financing Cash Flow	0	1	2	2	10	0	0	14	-13
Change in Cash	0	-2	0	0	9	-2	-5	11	-1

ImmunoPrecise Antibodies Ltd. Annual Cash Flow

All numbers in Millions USD

	Apr 2017	Apr 2018	Apr 2019	Apr 2020	Apr 2021	Apr 2022	Apr 2023	Apr 2024	Apr 2025
Net Income	-5	-5	-7	-4	-7	-16	-26	-27	-30
Operating Cash Flow	0	-3	-3	-1	0	-9	-19	-4	-6
Investing Cash Flow	0	-7	-2	-1	-2	-5	-1	-1	0
Financing Cash Flow	3	9	9	0	43	2	0	1	14
Change in Cash	2	0	3	-2	39	-11	-21	-4	7

Insights on ImmunoPrecise Antibodies Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, HYFT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, HYFT stock has moved up by 165.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 30.4% return, outperforming this stock by 97.7%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 4.16M → 4.09M (in $), with an average decrease of 1.8% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -2.10M → -3.86M (in $), with an average decrease of 23.3% per quarter

About ImmunoPrecise Antibodies Ltd.

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Organisation	ImmunoPrecise Antibodies Ltd.
Headquarters	Industrious 823 Congress Ave, Austin, TX, United States, 78701
Industry	Biotechnology
CEO	Dr. Jennifer Lynne Bath Ph.D.
E-voting on shares	Click here to vote

Key Management of ImmunoPrecise Antibodies Ltd.

Name	Title
Dr. Shuji Sato	Vice President of Innovative Solutions
Mr. Richard Scott Areglado	Chief Financial Officer
Ms. Kari Graber	Vice President of Commercial Services
Mr. Dirk Van Hyfte M.D., Ph.D.	Chief Technology Officer
Mr. Frederic Chabot	Head of Corporate Development
Ms. Ingrid Brands M.D., Ph.D.	Chief Innovation & Strategy Officer
Dr. Thomas Lynch Ph.D.	Chief Business Officer
Ms. Lori Anderson	Vice President of Brand Marketing and Creative
Dr. Jennifer Lynne Bath Ph.D.	CEO, President & Non-Independent Director

FAQs

What is ImmunoPrecise Antibodies Ltd. share price today?

ImmunoPrecise Antibodies Ltd. share price today is $1.27 as on May 13, 2026 at 1:29 am IST at the close of the market. ImmunoPrecise Antibodies Ltd. share today touched a day high of $1.31 and a low of $1.26.

What is the 52 week high and 52 week low for ImmunoPrecise Antibodies Ltd. share?

ImmunoPrecise Antibodies Ltd. share touched a 52 week high of $2.99 on January 12, 2026 and a 52 week low of $0.99 on March 30, 2026. ImmunoPrecise Antibodies Ltd. stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $1.27,which is 57.53% down from its 52 week high and 28.28% up from its 52 week low.

What is ImmunoPrecise Antibodies Ltd.'s market capitalisation today?

ImmunoPrecise Antibodies Ltd. market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in ImmunoPrecise Antibodies Ltd. Stock (HYFT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ImmunoPrecise Antibodies Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ImmunoPrecise Antibodies Ltd. Shares that will get you 1.1811 shares as per ImmunoPrecise Antibodies Ltd. share price of $1.27 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy ImmunoPrecise Antibodies Ltd. Stock (HYFT) from India?

Indian investors can start investing in ImmunoPrecise Antibodies Ltd. (HYFT) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in ImmunoPrecise Antibodies Ltd. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:39 am IST). Based on ImmunoPrecise Antibodies Ltd. share’s latest price of $1.27 as on May 13, 2026 at 1:29 am IST, you will get 7.8740 shares of ImmunoPrecise Antibodies Ltd.. Learn more about fractional shares .